Announcements Trials
Browse Landscape

Phase

Phase 1/2 1Phase 1 1

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2Dermatologic 1

Conditions

Lung Neoplasms 28Carcinoma, Non-Small-Cell Lung 21Urinary Bladder Neoplasms 3Melanoma 3Colorectal Neoplasms 3Adenocarcinoma of Lung 3Urogenital Neoplasms 2Small Cell Lung Carcinoma 2Pancreatic Neoplasms 2Colitis 2Carcinoma, Renal Cell 2Carcinoma, Neuroendocrine 2Uterine Neoplasms 1Uterine Cervical Neoplasms 1Urethral Neoplasms 1Ureteral Neoplasms 1Turcot syndrome 1Thyroid Neoplasms 1Stomach Neoplasms 1Rectal Neoplasms 1Radiation Pneumonitis 1Prostatic Neoplasms 1Ovarian Neoplasms 1Nasopharyngeal Neoplasms 1Nasopharyngeal Carcinoma 1Multiple Myeloma 1Mesothelioma, Malignant 1Lymphoma 1Hematologic Neoplasms 1Glioma 1

Interventions

vedolizumab 2LDP-02 2Infliximab 2Immunoglobulin G 2Fecal Microbiota Transplantation 2Disulfides 2CT-P13 2prednylidene 1deltacortene 1Standard of Care 1Prednisone 1Practice Guidelines as Topic 1Loperamide 1Endoscopy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Colitis × Disulfides × Thoracic × Clear all
NCT03819296 2026-03-11

Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer

M.D. Anderson Cancer Center

Phase 1 Recruiting
800 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Colitis, Lung Neoplasms, Urogenital Neoplasms

NCT04407247 2025-12-23

Infliximab or Vedolizumab in Treating Immune Checkpoint Inhibitor-Related Colitis in Patients With Genitourinary Cancer or Melanoma

M.D. Anderson Cancer Center

Phase 1/2 Active not recruiting
47 enrolled
DermatologicThoracic

Carcinoma, Non-Small-Cell Lung, Colitis, Melanoma, Urogenital Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡